Journal of affective disorders · 2025
Brain structural correlates of prior alcohol use disorder and their relation to cognitive impairment in individuals with mood disorders.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miskowiak Kamilla W, Bjerregaard Sofie M, Fink-Jensen Anders, Kessing Lars V, Damgaard Viktoria, Schandorff Johanna M, Kjærstad Hanne L, Macoveanu Julian, Frokjaer Vibe G, Knudsen Gitte M, Sankar Anjali
Аннотация
BACKGROUND: Alcohol use disorders (AUD) often co-occur with mood disorders (MD), negatively impacting the clinical course of both disorders and exacerbating cognitive impairments. Neuroimaging studies have demonstrated lower gray matter volume (GMV) and hippocampal volume in MD and AUD, and additionally in the orbitofrontal cortex (OFC), nucleus accumbens (NAc), and white matter (WM) volume in AUD. However, whether the pronounced structural alterations in MD persist after remission from AUD, and their relation to cognitive impairments, remains unclear.
METHOD: Individuals with MD with (MD + AUD; n = 42) or without (MD: n = 244) prior comorbid AUD, underwent structural magnetic resonance imaging and neuropsychological testing. We investigated differences in GMV and hippocampal volume between MD + AUD and MD groups, and their associations with cognitive function. Exploratory analyses also examined differences in volume of WM, NAc, and OFC between MD + AUD and MD groups.
RESULTS: The MD + AUD group had significantly lower GMV (p = 0.02) and hippocampal volume (p = 0.01) than MD group. Lower GMV was associated with poorer global cognition (p = 0.001), while smaller hippocampal volume scaled with lower verbal learning and memory function (p = 0.03). Lower volume was additionally observed in MD + AUD group in the OFC (p = 0.04) and NAc (p = 0.003), but not in WM.
CONCLUSION: Individuals with MD and prior AUD exhibit lower brain volume in regions that subserve higher cognitive function and vulnerable to alcohol-induced neurotoxicity. Our data suggests persistent neurobiological alterations despite remission from AUD, and support the use of integrated treatment approaches that enhance neuroplasticity and cognition.
METHOD: Individuals with MD with (MD + AUD; n = 42) or without (MD: n = 244) prior comorbid AUD, underwent structural magnetic resonance imaging and neuropsychological testing. We investigated differences in GMV and hippocampal volume between MD + AUD and MD groups, and their associations with cognitive function. Exploratory analyses also examined differences in volume of WM, NAc, and OFC between MD + AUD and MD groups.
RESULTS: The MD + AUD group had significantly lower GMV (p = 0.02) and hippocampal volume (p = 0.01) than MD group. Lower GMV was associated with poorer global cognition (p = 0.001), while smaller hippocampal volume scaled with lower verbal learning and memory function (p = 0.03). Lower volume was additionally observed in MD + AUD group in the OFC (p = 0.04) and NAc (p = 0.003), but not in WM.
CONCLUSION: Individuals with MD and prior AUD exhibit lower brain volume in regions that subserve higher cognitive function and vulnerable to alcohol-induced neurotoxicity. Our data suggests persistent neurobiological alterations despite remission from AUD, and support the use of integrated treatment approaches that enhance neuroplasticity and cognition.